Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Phaeodactylum tricornutum 50S ribosomal protein L29, chloroplastic (rpl29) CSB-YP372008EUF
CSB-EP372008EUF
CSB-BP372008EUF
CSB-MP372008EUF
CSB-EP372008EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum 50S ribosomal protein L24, chloroplastic (rpl24) CSB-YP372009EUF
CSB-EP372009EUF
CSB-BP372009EUF
CSB-MP372009EUF
CSB-EP372009EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum 50S ribosomal protein L6, chloroplastic (rpl6) CSB-YP372010EUF
CSB-EP372010EUF
CSB-BP372010EUF
CSB-MP372010EUF
CSB-EP372010EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum 50S ribosomal protein L18, chloroplastic (rpl18) CSB-YP372011EUF
CSB-EP372011EUF
CSB-BP372011EUF
CSB-MP372011EUF
CSB-EP372011EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum 30S ribosomal protein S9, chloroplastic (rps9) CSB-YP372012EUF
CSB-EP372012EUF
CSB-BP372012EUF
CSB-MP372012EUF
CSB-EP372012EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum 30S ribosomal protein S12, chloroplastic (rps12) CSB-YP372013EUF
CSB-EP372013EUF
CSB-BP372013EUF
CSB-MP372013EUF
CSB-EP372013EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum Elongation factor Tu, chloroplastic (tufA) CSB-YP372014EUF
CSB-EP372014EUF
CSB-BP372014EUF
CSB-MP372014EUF
CSB-EP372014EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum Photosystem II reaction center protein Z (psbZ), partial CSB-YP372015EUF1
CSB-EP372015EUF1
CSB-BP372015EUF1
CSB-MP372015EUF1
CSB-EP372015EUF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum Photosystem II reaction center protein ycf12 (ycf12), partial CSB-YP372016EUF
CSB-EP372016EUF
CSB-BP372016EUF
CSB-MP372016EUF
CSB-EP372016EUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeodactylum tricornutum Photosystem I reaction center subunit XI (psaL), partial CSB-YP372017EUF1
CSB-EP372017EUF1
CSB-BP372017EUF1
CSB-MP372017EUF1
CSB-EP372017EUF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana Photosystem I P700 chlorophyll a apoprotein A1 (psaA), partial CSB-YP372018TLZ
CSB-EP372018TLZ
CSB-BP372018TLZ
CSB-MP372018TLZ
CSB-EP372018TLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana Photosystem II reaction center X protein (psbX), partial CSB-YP372019TLZ
CSB-EP372019TLZ
CSB-BP372019TLZ
CSB-MP372019TLZ
CSB-EP372019TLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana ATP synthase subunit c, chloroplastic (atpH), partial CSB-YP372020TLZ1
CSB-EP372020TLZ1
CSB-BP372020TLZ1
CSB-MP372020TLZ1
CSB-EP372020TLZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana Photosystem II reaction center protein T (psbT), partial CSB-YP372021TLZ
CSB-EP372021TLZ
CSB-BP372021TLZ
CSB-MP372021TLZ
CSB-EP372021TLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana Photosystem II reaction center protein H (psbH), partial CSB-YP372022TLZ1
CSB-EP372022TLZ1
CSB-BP372022TLZ1
CSB-MP372022TLZ1
CSB-EP372022TLZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana 50S ribosomal protein L20, chloroplastic (rpl20) CSB-YP372023TLZ
CSB-EP372023TLZ
CSB-BP372023TLZ
CSB-MP372023TLZ
CSB-EP372023TLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana 50S ribosomal protein L12, chloroplastic (rpl12) CSB-YP372024TLZ
CSB-EP372024TLZ
CSB-BP372024TLZ
CSB-MP372024TLZ
CSB-EP372024TLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana DNA-directed RNA polymerase subunit beta' (rpoC1), partial CSB-YP372025TLZ
CSB-EP372025TLZ
CSB-BP372025TLZ
CSB-MP372025TLZ
CSB-EP372025TLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana Photosystem I assembly protein ycf3 (ycf3) CSB-YP372026TLZ
CSB-EP372026TLZ
CSB-BP372026TLZ
CSB-MP372026TLZ
CSB-EP372026TLZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira pseudonana Apocytochrome f (petA), partial CSB-YP372027TLZ1
CSB-EP372027TLZ1
CSB-BP372027TLZ1
CSB-MP372027TLZ1
CSB-EP372027TLZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>